
Global Tafenoquine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Tafenoquine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tafenoquine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Tafenoquine, also provides the sales of main regions and countries. Of the upcoming market potential for Tafenoquine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tafenoquine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tafenoquine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Tafenoquine sales, projected growth trends, production technology, application and end-user industry.
Tafenoquine Segment by Company
Pharmacodia (Beijing) Co.,Ltd
Merck
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
BOC Sciences
Amadis Chemical Company Limited
Tafenoquine Segment by Type
Powder
Pills
Tafenoquine Segment by Application
P. falciparum Treatment
Radical Cure of P.vivax
Prevention of Malaria Relapse
Tafenoquine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tafenoquine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
According to APO Research, The global Tafenoquine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Tafenoquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tafenoquine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Tafenoquine, also provides the sales of main regions and countries. Of the upcoming market potential for Tafenoquine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tafenoquine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tafenoquine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Tafenoquine sales, projected growth trends, production technology, application and end-user industry.
Tafenoquine Segment by Company
Pharmacodia (Beijing) Co.,Ltd
Merck
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
BOC Sciences
Amadis Chemical Company Limited
Tafenoquine Segment by Type
Powder
Pills
Tafenoquine Segment by Application
P. falciparum Treatment
Radical Cure of P.vivax
Prevention of Malaria Relapse
Tafenoquine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tafenoquine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table of Contents
187 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Tafenoquine Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Tafenoquine Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Tafenoquine Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Tafenoquine Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Tafenoquine Market Dynamics
- 2.1 Tafenoquine Industry Trends
- 2.2 Tafenoquine Industry Drivers
- 2.3 Tafenoquine Industry Opportunities and Challenges
- 2.4 Tafenoquine Industry Restraints
- 3 Tafenoquine Market by Manufacturers
- 3.1 Global Tafenoquine Revenue by Manufacturers (2020-2025)
- 3.2 Global Tafenoquine Sales by Manufacturers (2020-2025)
- 3.3 Global Tafenoquine Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Tafenoquine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Tafenoquine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tafenoquine Manufacturers, Product Type & Application
- 3.7 Global Tafenoquine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tafenoquine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2024
- 3.8.3 2024 Tafenoquine Tier 1, Tier 2, and Tier 3
- 4 Tafenoquine Market by Type
- 4.1 Tafenoquine Type Introduction
- 4.1.1 Powder
- 4.1.2 Pills
- 4.2 Global Tafenoquine Sales by Type
- 4.2.1 Global Tafenoquine Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Tafenoquine Sales by Type (2020-2031)
- 4.2.3 Global Tafenoquine Sales Market Share by Type (2020-2031)
- 4.3 Global Tafenoquine Revenue by Type
- 4.3.1 Global Tafenoquine Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Tafenoquine Revenue by Type (2020-2031)
- 4.3.3 Global Tafenoquine Revenue Market Share by Type (2020-2031)
- 5 Tafenoquine Market by Application
- 5.1 Tafenoquine Application Introduction
- 5.1.1 P. falciparum Treatment
- 5.1.2 Radical Cure of P.vivax
- 5.1.3 Prevention of Malaria Relapse
- 5.2 Global Tafenoquine Sales by Application
- 5.2.1 Global Tafenoquine Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Tafenoquine Sales by Application (2020-2031)
- 5.2.3 Global Tafenoquine Sales Market Share by Application (2020-2031)
- 5.3 Global Tafenoquine Revenue by Application
- 5.3.1 Global Tafenoquine Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Tafenoquine Revenue by Application (2020-2031)
- 5.3.3 Global Tafenoquine Revenue Market Share by Application (2020-2031)
- 6 Global Tafenoquine Sales by Region
- 6.1 Global Tafenoquine Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Tafenoquine Sales by Region (2020-2031)
- 6.2.1 Global Tafenoquine Sales by Region (2020-2025)
- 6.2.2 Global Tafenoquine Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Tafenoquine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Tafenoquine Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tafenoquine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Tafenoquine Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tafenoquine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Tafenoquine Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Tafenoquine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Tafenoquine Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Tafenoquine Revenue by Region
- 7.1 Global Tafenoquine Revenue by Region
- 7.1.1 Global Tafenoquine Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Tafenoquine Revenue by Region (2020-2025)
- 7.1.3 Global Tafenoquine Revenue by Region (2026-2031)
- 7.1.4 Global Tafenoquine Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Tafenoquine Revenue (2020-2031)
- 7.2.2 North America Tafenoquine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Tafenoquine Revenue (2020-2031)
- 7.3.2 Europe Tafenoquine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Tafenoquine Revenue (2020-2031)
- 7.4.2 Asia-Pacific Tafenoquine Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Tafenoquine Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Tafenoquine Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Pharmacodia (Beijing) Co.,Ltd
- 8.1.1 Pharmacodia (Beijing) Co.,Ltd Comapny Information
- 8.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
- 8.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
- 8.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
- 8.2 Merck
- 8.2.1 Merck Comapny Information
- 8.2.2 Merck Business Overview
- 8.2.3 Merck Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Merck Tafenoquine Product Portfolio
- 8.2.5 Merck Recent Developments
- 8.3 GlaxoSmithKline Pharmaceuticals (GSK)
- 8.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Comapny Information
- 8.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
- 8.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
- 8.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
- 8.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
- 8.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Comapny Information
- 8.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
- 8.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
- 8.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
- 8.5 J & K Scientific LTD
- 8.5.1 J & K Scientific LTD Comapny Information
- 8.5.2 J & K Scientific LTD Business Overview
- 8.5.3 J & K Scientific LTD Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
- 8.5.5 J & K Scientific LTD Recent Developments
- 8.6 BOC Sciences
- 8.6.1 BOC Sciences Comapny Information
- 8.6.2 BOC Sciences Business Overview
- 8.6.3 BOC Sciences Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 BOC Sciences Tafenoquine Product Portfolio
- 8.6.5 BOC Sciences Recent Developments
- 8.7 Amadis Chemical Company Limited
- 8.7.1 Amadis Chemical Company Limited Comapny Information
- 8.7.2 Amadis Chemical Company Limited Business Overview
- 8.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
- 8.7.5 Amadis Chemical Company Limited Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Tafenoquine Value Chain Analysis
- 9.1.1 Tafenoquine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tafenoquine Production Mode & Process
- 9.2 Tafenoquine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tafenoquine Distributors
- 9.2.3 Tafenoquine Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.